<!DOCTYPE html>
<html>

<head>
    <title>LINHA DO TEMPO HIV</title>

    <meta charset="utf-8" />
    <meta charset="UTF-8">
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@300;400;600&display=swap" rel="stylesheet" />
    <link rel="stylesheet" href="css/bootstrap.min.css" />
    <!-- <link rel="stylesheet" href="css/stylelais.css" /> -->
    

    <link rel="shortcut icon" href="">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <link href='https://fonts.googleapis.com/css?family=Playfair+Display:700,900|Fira+Sans:400,400italic'
        rel='stylesheet' type='text/css'>
    <link rel="stylesheet" href="css/reset.css"> <!-- CSS reset -->
    <link rel="stylesheet" href="css/style.css"> <!-- Resource style -->
    <script src="js/modernizr.js"></script> <!-- Modernizr -->
    <script src="js/jquery-2.1.4.js"></script>
    <script src="js/jquery.mobile.custom.min.js"></script>
    <script src="js/jtline.js"></script>
    <script type="text/javascript">


        $(document).ready(function () {
            var contentText = 'Lorem ipsum dolor sit amet, consectetur adipisicing elit.';

            // dataRoot : '/'
            var myMappedObject = [
                {
                    "isSelected": "true",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": " 1977-78 ",
                    "assignDate": "01/01/1978",
                    "taskShortDate": "1977-78",
                    "taskDetails": "First AIDS cases in the United States, Haiti, and Africa."

                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Event",
                    "taskSubTitle": "1982",
                    "assignDate": "01/01/1982",
                    "taskShortDate": "1982",
                    "taskDetails": "The first case of HIV in Brazil."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Events",
                    "taskSubTitle": "1983",
                    "assignDate": "01/01/1983",
                    "taskShortDate": "1983",
                    "taskDetails": "The first case of HIV in a child and a woman in Brazil.<br>\n Discovery of HIV.<br>"
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level and Brazil-level Event",
                    "taskSubTitle": "1985",
                    "assignDate": "01/01/1985",
                    "taskShortDate": "1985",
                    "taskDetails": "&#8226;The first anti-HIV test emerges. <br> <br>\n  &#8226;A national program for addressing HIV is created."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Events",
                    "taskSubTitle": "1987",
                    "assignDate": "01/01/1987",
                    "taskShortDate": "1987",
                    "taskDetails": "Brazil starts using Zidovudine (ZDV).<br>\n Brazil records 2775 cases.<br>\n"
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Event",
                    "taskSubTitle": "1988",
                    "assignDate": "01/01/1988",
                    "taskShortDate": "1988",
                    "taskDetails": "Creation of the Unified Health System (SUS). \n"
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level and Brazil-level Event",
                    "taskSubTitle": "1991",
                    "assignDate": "01/01/1991",
                    "taskShortDate": "1991",
                    "taskDetails": "&#8226; Globally, there are 10 million HIV-infected people (according to WHO).<br><br>\n &#8226; Acquisition of antiretroviral drugs (ARVs) by the Ministry of Health - universal access to ARVs. "
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "1992",
                    "assignDate": "01/01/1992",
                    "taskShortDate": "1992",
                    "taskDetails": "DDidanosine (ddI) and Zalcitabine (ddC) are approved for combined use with ZDV."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "1994",
                    "assignDate": "01/01/1994",
                    "taskShortDate": "1994",
                    "taskDetails": "Stavudine (d4T) is approved for use."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "1995",
                    "assignDate": "01/01/1995",
                    "taskShortDate": "1995",
                    "taskDetails": "Lamivudine (3TC) is approved for use saquinavir (SQV)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level and Brazil-level Events",
                    "taskSubTitle": "1996",
                    "assignDate": "01/01/1996",
                    "taskShortDate": "1996",
                    "taskDetails": "&#8226; Nevirapine (NVP). <br> &#8226; New ARV class, the protease inhibitor: Inadivir (IDV), Ritonavir (RTV).<br><br> &#8226; Law No. 9313 guarantees universal access to treatment for HIV infection as a right - thus being the first developing country to do so."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "1997",
                    "assignDate": "101/01/1997",
                    "taskShortDate": "1997",
                    "taskDetails": "Nelfinavir (NFV)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Events",
                    "taskSubTitle": "1998",
                    "assignDate": "01/01/1998",
                    "taskShortDate": "1998",
                    "taskDetails": "Evidence of triple therapy's effectiveness in reducing morbidity and mortality. <br> \n Lauching of Efavirenz (EFZ)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "2000",
                    "assignDate": "01/01/2000",
                    "taskShortDate": "2000",
                    "taskDetails": "Lopinavir/ritonavir."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "2001",
                    "assignDate": "01/01/2001",
                    "taskShortDate": "2001",
                    "taskDetails": "Tenofovir Disoproxil Fumarate ((TDF)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Events",
                    "taskSubTitle": "2003",
                    "assignDate": "01/01/2003",
                    "taskShortDate": "2003",
                    "taskDetails": "Atanazavir. <br> Fosamprenavir. <br> Enfuvirtide (t20)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Event",
                    "taskSubTitle": "2006",
                    "assignDate": "01/01/2006",
                    "taskShortDate": "2006",
                    "taskDetails": "Darunavir (DVR)."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Global-level Events",
                    "taskSubTitle": "2007",
                    "assignDate": "01/01/2007",
                    "taskShortDate": "2007",
                    "taskDetails": "Raltegravir. <br> Maraviroc."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Evento no mundo e Brasil",
                    "taskSubTitle": "2008",
                    "assignDate": "01/01/2008",
                    "taskShortDate": "2008",
                    "taskDetails": "&#8226;Etravirina. <br><br> &#8226;ART for people who have a CD4 cell count below 200 ART for people with a CD4 count between 200 and 350 depending on the tendency of CD4 count decrease and/or viral load elevation, the patient's motivation to start treatment, his/her adhesion to treatment, and the presence of comorbidities"
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Events",
                    "taskSubTitle": "2010",
                    "assignDate": "01/01/2010",
                    "taskShortDate": "2010",
                    "taskDetails": "ART for people who have a CD4 cell count below 350. <br> Outset of Post-Exposure Prophylaxis (PEP). "
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Events",
                    "taskSubTitle": "2013",
                    "assignDate": "01/01/2010",
                    "taskShortDate": "2013",
                    "taskDetails": "ART treatment for people with CD4 below 500 cells/mm3."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Event",
                    "taskSubTitle": "2016",
                    "assignDate": "01/01/2015",
                    "taskShortDate": "2016",
                    "taskDetails": "Dolutegravir added to the preferred scheme for treatment-naive patients."
                },
                {
                    "isSelected": "",
                    "taskTitle": "Brazil-level Events",
                    "taskSubTitle": "2018",
                    "assignDate": "01/01/2018",
                    "taskShortDate": "2018",
                    "taskDetails": "Outset of PreP (Pre-Exposure Prophylaxis in Brazil). <br> TTreatment for all people living with HIV - test and treat."
                }
            ];

            var jtLine = $('.myjtline').jTLine({
                callType: 'jsonObject',
                structureObj: myMappedObject,
                map: {
                    "dataRoot": "/",
                    "title": "taskTitle",
                    "subTitle": "taskSubTitle",
                    "dateValue": "assignDate",
                    "pointCnt": "taskShortDate",
                    "bodyCnt": "taskDetails"
                },
                distanceMode: 'fixDistance', // 'fixDistance' 'auto' 'predefinedDistance'
                eventsMinDistance: 100,       // Consider It as Distance Unit "by Pixel"
                fixDistanceValue: 2,         // if eventsMinDistance = 60 & fixDistanceValue= 2 then the value is: (60*2) = 120 px
                firstPointMargin: 1         // First Point Margin from the left
            });
        });
    </script>
</head>

<body>

    <header class="header">
        <div class="container">
            <h1>Linha do Tempo:</h1>
            <h1>HIV</h1>
        </div>
    </header>
    
    <section id="conteudo" class="container">    
        <div class="myjtline">
        </div>
        <p style="text-align: center;">Fonte: DCCI/SVS/MS</p>
    </section>
    <span class="line"></span>

    <script src="js/dark-mode-switch.min.js"></script>
 
</body>

</html>
